Norden Group’s Gilead Sciences GILD Stock Holding History

Norden Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.94M	Buy	31,176 +879	+3%	+$116K	0.32%	63
2026 Q1	$4.22M	Sell	30,297 -750	-2%	-$105K	0.41%	52
2025 Q4	$3.81M	Buy	31,047 +438	+1%	+$53.2K	0.37%	54
2025 Q3	$3.4M	Sell	30,609 -43,162	-59%	-$4.91M	0.35%	57
2025 Q2	$8.18M	Buy	73,771 +46,725	+173%	+$4.97M	0.89%	18
2025 Q1	$3.03M	Buy	27,046 +942	+4%	+$97.2K	0.35%	59
2024 Q4	$2.41M	Buy	26,104 +345	+1%	+$31.1K	0.27%	82
2024 Q3	$2.16M	Buy	25,759 +15,653	+155%	+$1.19M	0.25%	88
2024 Q2	$693K	Sell	10,106 -1,973	-16%	-$132K	0.14%	160
2024 Q1	$885K	Sell	12,079 -15,084	-56%	-$1.16M	0.18%	128
2023 Q4	$2.2M	Buy	27,163 +19,177	+240%	+$1.49M	0.38%	26
2023 Q3	$598K	Buy	+7,986	New	+$614K	0.2%	118

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norden Group's GILD Position: Q2 2026 in Review

Norden Group increased its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, buying an estimated $116K and bringing the position to 31,176 shares worth $3.94M. The position accounts for 0.32% of the portfolio, ranked #63.

Norden Group first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.18M in Q2 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Norden Group held 31,176 shares of Gilead Sciences worth $3.94M as of Q2 2026.
Norden Group bought 879 Gilead Sciences shares in Q2 2026, an estimated $116K.
Gilead Sciences made up 0.32% of Norden Group's portfolio in Q2 2026, its #63 holding.
Norden Group first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
Norden Group's Gilead Sciences position peaked at $8.18M in Q2 2025.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.